XellSmart Gets FDA Clearance for 3 Phase I INDs in CNS Cell Therapies
XellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the development of innovative iPSC-derived cell therapies. To date, the company has...